Literature DB >> 12110057

Inappropriate prescribing before and after nursing home admission.

Irfan A Dhalla1, Geoffrey M Anderson, Muhammad M Mamdani, Susan E Bronskill, Kathy Sykora, Paula A Rochon.   

Abstract

OBJECTIVES: To compare the prevalence of inappropriate prescribing before and after nursing home admission and to determine which patient and physician characteristics are associated with inappropriate prescribing in the nursing home setting.
DESIGN: A pre/post retrospective, cohort study.
SETTING: All licensed nursing homes in Ontario, Canada. PARTICIPANTS: Nineteen thousand nine hundred eleven individuals aged 66 and older, newly admitted to nursing homes in Ontario between April 1, 1997, and March 31, 1999. MEASUREMENTS: For each patient in the cohort, a subset of the Beers criteria was used to characterize and compare the prevalence of inappropriate prescribing (as indicated by the prescription of one of 49 inappropriate drugs) before and after nursing home admission. A logistic regression model was used to study the association between inappropriate prescribing and patient and physician characteristics.
RESULTS: The proportion of patients receiving a prescription for at least one inappropriate drug decreased from 25.4% before nursing home admission to 20.8% afterward (P <.001). Most patients who had been prescribed an inappropriate agent before nursing home entry had that agent discontinued after admission. The most commonly prescribed inappropriate drugs after nursing home admission were strongly anticholinergic antidepressants (6.4%) and long-half-life benzodiazepines (5.9%). Patients younger than 85 were more likely to receive inappropriate drug therapy (odds ratio (OR) = 1.25, 95% confidence interval (CI) = 1.15-1.35) than those aged 85 and older. Other significant predictors were having more than one prescriber (OR = 1.40, 95% CI = 1.29-1.51), having a physician aged 50 or older (OR = 1.14, 95% CI = 1.05-1.23), having a male physician (OR = 1.20, 95% CI = 1.05-1.37), having a nonspecialist physician (OR = 1.23, 95% CI = 1.01-1.49), having a nonurban physician (OR = 1.13, 95% CI = 1.03-1.24), and having a physician practicing outside the greater Ontario metropolitan area (OR = 1.31, 95% CI = 1.19-1.51).
CONCLUSIONS: Although a substantial number of nursing home residents receive inappropriate drug therapy, the prevalence of inappropriate prescriptions in our cohort declined after nursing home admission despite an overall increase in drug use. Patient and physician characteristics were associated with inappropriate prescribing. Targeted interventions such as regionally based education programs or drug use restrictions may reduce the prevalence of inappropriate prescribing.

Entities:  

Mesh:

Year:  2002        PMID: 12110057     DOI: 10.1046/j.1532-5415.2002.50252.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

Review 1.  Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.

Authors:  Michelle A King; Michael S Roberts
Journal:  Pharm World Sci       Date:  2007-02

3.  Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use.

Authors:  Marie-Laure Laroche; Jean-Pierre Charmes; Yves Nouaille; Annie Fourrier; Louis Merle
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

5.  Use of inappropriate medications and their prognostic significance among in-hospital and nursing home patients with and without dementia in Finland.

Authors:  Minna M Raivio; Jouko V Laurila; Timo E Strandberg; Reijo S Tilvis; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Authors:  Jonny Olsson; Asa Bergman; Anders Carlsten; Thimothy Oké; Cecilia Bernsten; Ingrid K Schmidt; Johan Fastbom
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

7.  Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.

Authors:  Joshua Niznik; Xinhua Zhao; Tao Jiang; Joseph T Hanlon; Sherrie L Aspinall; Joshua Thorpe; Carolyn Thorpe
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

8.  Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects.

Authors:  C Trivalle; T Cartier; C Verny; A-M Mathieu; P Davrinche; H Agostini; L Becquemont; P Demolis
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

9.  Management of hypertension in elderly long-term care residents.

Authors:  Ross T Tsuyuki; Donna L McLean; Finlay A McAlister
Journal:  Can J Cardiol       Date:  2008-12       Impact factor: 5.223

10.  Fall-related injuries in a nursing home setting: is polypharmacy a risk factor?

Authors:  Federico Baranzini; Marcello Diurni; Francesca Ceccon; Nicola Poloni; Sara Cazzamalli; Chiara Costantini; Cristiano Colli; Laura Greco; Camilla Callegari
Journal:  BMC Health Serv Res       Date:  2009-12-11       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.